This topic contains 0 replies, has 1 voice, and was last updated by 
-
Posts
-
Vertex is asking FDA approval of elexacaftor (VX-445), tezacaftor, and ivacaftor (Kalydeco) to treat CF patients unable to benefit with current therapies. Read more about it here.
How do you feel about this news?
You must be logged in to reply to this topic.
